Federal Judge Rejects FDA’s 75 Year Lag on Pfizer COVID Vaccine Data, Orders 55,000 Pages Per Month
Updated
By Jefferey Jaxen
A lawsuit brought against the U.S. Food and Drug Administration (FDA) by the Public Health and Medical Professionals for Transparency (PHMPT) has just been catapulted to international attention – and for good reason.
The original Freedom of Information Act Request (FOIA) brought by attorney Aaron Siri of Siri Glimstad on behalf of PHMPT sought from the FDA all the data submitted by Pfizer to license its Covid-19 vaccine. After that FOIA was ignored, a suit was brought to which the parties failed to agree to a mutually acceptable production schedule of the more than 329,000+ pages held by the FDA.
PHMPT wanted FDA’s Pfizer’s data out in the public domain sooner than later…the FDA asked the Court for permission to only be required to produce at a rate of 500 pages per month, which would have taken over 75 years to produce all the documents.
However, in a new court ruling yesterday, The U.S. District Court for the Northern District of Texas Fort Worth Division “has soundly rejected the FDA’s request and ordered the agency to produce all the data at a clip of 55,000 pages per month” writes Siri at his Substack account Injecting Freedom.
Judge Mark T. Pittman order states “The FDA shall produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.”
Commenting on the federal judge’s recent order, Siri stated:
“This is a great win for transparency and removes one of the strangleholds federal “health” authorities have had on the data needed for independent scientists to offer solutions and address serious issues with the current vaccine program – issues which include waning immunity, variants evading vaccine immunity, and, as the CDC has confirmed, that the vaccines do not prevent transmission.”
While the world now waits for the FDA to drop the first 55,000 documents on March 1, it bears repeating what the agency’s earlier trickle of documents has already revealed. For a full review, see our reporting here at The HighWire covering the data.
The early pages, which can be downloaded here, show that in the 2 ½ months following EUA, Pfizer received a total of 42,086 reports containing 158,893 “events.” Most of these reports were from the U.S. and disproportionately involved women (29,914 vs. 9,182 provided by men) and those between 31 and 50 years old (13,886 vs 21,325 for all other age groups combined, with another 6,876 whose ages were unknown). Also, 25,957 of the events were classified as “Nervous system disorders”
There were also 1,223 case outcomes listed as ‘fatal.’
